On March 11, 2021 InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, reported that it will host a conference call to discuss the 2020 full year financial results and provide a corporate update at 9:00 a.m. Beijing time on March 29, 2021 (Press release, InnoCare Pharma, MAR 11, 2021, View Source [SID1234576541]). Before the call, the Company will announce the financial results for the full year ended December 31, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information

InnoCare will host a conference call on March 29, 2021 at 9:00 a.m. Beijing time. Participants must register in advance of the conference call. Details are as follows:

Registration Link: View Source

Conference ID: 4956225

The call will be conducted in English.

Upon registering, each participant will receive a dial-in number, Direct Event passcode, and a unique access PIN, which can be used to join the conference call.

A replay will be available on the Company’s website at Investor Relations page.